Repositioning Candidate Details
| Candidate ID: | R0908 |
| Source ID: | DB05971 |
| Source Type: | investigational |
| Compound Type: | small molecule |
| Compound Name: | Archexin |
| Synonyms: | -- |
| Molecular Formula: | -- |
| SMILES: | -- |
| DrugBank Description: | -- |
| CAS Number: | -- |
| Molecular Weight: | |
| DrugBank Indication: | Investigated for use/treatment in solid tumors. |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | RX-0201 is a first-in-class signal inhibitor that directly represses the production of Akt, a protein kinase that plays a key role in cancer progression. A less toxic therapeutic approach to cancer treatment, RX-0201 blocks the growth of tumor cells and promotes cell death (apoptosis). |
| Targets: | RAC-alpha serine/threonine-protein kinase |
| Inclusion Criteria: | Therapeutic strategy associated |
